Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 2
Submit an article Journal homepage
2,253
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of the safety and efficacy of humanized anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma based on the comprehensive geriatric assessment system

Huan Zhanga Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
,
Man Liub Department of Surgery Plastic, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
,
Qing Lia Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
,
Cuicui Lyua Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
,
Yan-Yu Jianga Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
,
Juan-Xia Menga Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
,
Jing-Yi Lia Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
&
Qi Denga Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaCorrespondence[email protected]
 show all
Pages 353-361 | Received 11 May 2021, Accepted 20 Sep 2021, Published online: 29 Sep 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.